{"id":"https://openalex.org/W1986881091","doi":"https://doi.org/10.1038/clpt.2009.215","title":"Delays in New Drug Applications in Japan and Industrial R&D Strategies","display_name":"Delays in New Drug Applications in Japan and Industrial R&D Strategies","publication_year":2009,"publication_date":"2009-11-25","ids":{"openalex":"https://openalex.org/W1986881091","doi":"https://doi.org/10.1038/clpt.2009.215","mag":"1986881091","pmid":"https://pubmed.ncbi.nlm.nih.gov/19940847"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.2009.215","doi":"https://doi.org/10.1038/clpt.2009.215","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2009.215","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Y Hirai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y Hirai","raw_affiliation_strings":["Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011031407","display_name":"Hiroto Kinoshita","orcid":"https://orcid.org/0000-0002-8179-6017","observed_orcids":["https://orcid.org/0000-0002-8179-6017"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"H Kinoshita","raw_affiliation_strings":["Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079594025","display_name":"Makiko Kusama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M Kusama","raw_affiliation_strings":["Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061173143","display_name":"Kazuto Yasuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Yasuda","raw_affiliation_strings":["Office of Pharmaceutical Industry Research, Japan Pharmaceutical Manufacturers Association, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Pharmaceutical Industry Research, Japan Pharmaceutical Manufacturers Association, Tokyo, Japan","institution_ids":["https://openalex.org/I4405255266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027984186","display_name":"Yuichi Sugiyama","orcid":"https://orcid.org/0000-0002-8452-8835","observed_orcids":["https://orcid.org/0000-0002-8452-8835"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y Sugiyama","raw_affiliation_strings":["Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091099191","display_name":"Shunsuke Ono","orcid":"https://orcid.org/0000-0001-7941-0464","observed_orcids":["https://orcid.org/0000-0001-7941-0464"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"S Ono","raw_affiliation_strings":["Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Regulatory Sciences, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5091099191"],"corresponding_institution_ids":["https://openalex.org/I74801974"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":8.9218,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.97227719,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"87","issue":"2","first_page":"212","last_page":"218"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/new-drug-application","display_name":"new drug applications","score":0.8109999895095825},{"id":"https://openalex.org/keywords/drug-approval-time","display_name":"drug approval time","score":0.48100000619888306},{"id":"https://openalex.org/keywords/access-to-new-drugs","display_name":"access to new drugs","score":0.7279999852180481},{"id":"https://openalex.org/keywords/bridging-strategy","display_name":"bridging strategy","score":0.7260000109672546},{"id":"https://openalex.org/keywords/multinational-pharmaceutical-companies","display_name":"multinational pharmaceutical companies","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C2780560020","wikidata":"https://www.wikidata.org/wiki/Q79719","display_name":"License","level":2,"score":0.6379696130752563},{"id":"https://openalex.org/C158016649","wikidata":"https://www.wikidata.org/wiki/Q161726","display_name":"Multinational corporation","level":2,"score":0.6337509751319885},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6127908229827881},{"id":"https://openalex.org/C182306322","wikidata":"https://www.wikidata.org/wiki/Q1779371","display_name":"Order (exchange)","level":2,"score":0.5396919250488281},{"id":"https://openalex.org/C2779962950","wikidata":"https://www.wikidata.org/wiki/Q5659376","display_name":"Harmonization","level":2,"score":0.5364855527877808},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.4947144687175751},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.4702640473842621},{"id":"https://openalex.org/C174348530","wikidata":"https://www.wikidata.org/wiki/Q188635","display_name":"Bridging (networking)","level":2,"score":0.432412326335907},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.4283022880554199},{"id":"https://openalex.org/C2987767877","wikidata":"https://www.wikidata.org/wiki/Q352862","display_name":"Time lag","level":3,"score":0.42724713683128357},{"id":"https://openalex.org/C27548731","wikidata":"https://www.wikidata.org/wiki/Q88272","display_name":"Investment (military)","level":3,"score":0.4177091419696808},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.3960617780685425},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.3489401936531067},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.3258827030658722},{"id":"https://openalex.org/C75778745","wikidata":"https://www.wikidata.org/wiki/Q342626","display_name":"Lag","level":2,"score":0.314640074968338},{"id":"https://openalex.org/C155202549","wikidata":"https://www.wikidata.org/wiki/Q178803","display_name":"International trade","level":1,"score":0.2617611885070801},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.219483882188797},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.2185436189174652},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.17535719275474548},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1752932071685791},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.12372282147407532},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0},{"id":"https://openalex.org/C94625758","wikidata":"https://www.wikidata.org/wiki/Q7163","display_name":"Politics","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D003132","descriptor_name":"Commerce","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007391","descriptor_name":"International Cooperation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D017387","descriptor_name":"Investigational New Drug Application","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/clpt.2009.215","doi":"https://doi.org/10.1038/clpt.2009.215","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2009.215","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:19940847","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19940847","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G6688785027","display_name":"Exploring international differences in approved doses of drugs","funder_award_id":"21790109","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1895993106","https://openalex.org/W2011013179","https://openalex.org/W2028368078","https://openalex.org/W2125416781","https://openalex.org/W2508141910","https://openalex.org/W2891211072"],"related_works":["https://openalex.org/W4206288528","https://openalex.org/W4393928408","https://openalex.org/W2010072448","https://openalex.org/W2062301656","https://openalex.org/W3186763341","https://openalex.org/W2588908415","https://openalex.org/W2030234436","https://openalex.org/W4360944179","https://openalex.org/W4403110033","https://openalex.org/W2164061600"],"abstract_inverted_index":{"The":[0,61],"gap":[1,205],"between":[2,129],"Japan":[3],"and":[4,10,40,49,76,87,169,196],"both":[5],"the":[6,11,31,47,50,56,96,109,127,130,134,153,185,200,204],"United":[7],"States":[8],"(US)":[9],"European":[12],"Union":[13],"(EU)":[14],"with":[15,95],"regard":[16],"to":[17,19,54,65,82,122,148,161,174,202,208],"access":[18,207],"new":[20,36,209],"drugs":[21],"is":[22],"becoming":[23],"a":[24],"major":[25],"issue":[26],"in":[27,35,45,52,108,179,206],"Japan.":[28,180],"We":[29],"analyzed":[30],"time":[32,62],"lags":[33],"involved":[34],"drug":[37],"application":[38,43],"(NDA)":[39],"biological":[41],"license":[42],"submissions":[44],"Japan,":[46],"US,":[48],"EU":[51],"order":[53],"identify":[55],"causes":[57],"of":[58,67,84,90,104,155],"delayed":[59],"access.":[60],"lag":[63],"related":[64,81],"submission":[66,97,124],"applications":[68],"(\"submission":[69],"lag\")":[70],"was":[71,137],"longer":[72],"for":[73,77],"in-licensed":[74],"products":[75,178],"non-Japanese":[78],"companies.":[79],"Factors":[80],"costs":[83,168],"clinical":[85,106,110,186],"studies":[86],"potential":[88],"volumes":[89],"sales":[91,171],"were":[92],"not":[93],"associated":[94],"lag.":[98],"A":[99],"bridging":[100],"strategy":[101],"(extrapolative":[102],"use":[103],"foreign":[105],"data":[107,111],"package":[112],"based":[113],"on":[114,117,152,166,194],"International":[115],"Conference":[116],"Harmonisation":[118],"guideline":[119],"E5)":[120],"seemed":[121],"reduce":[123],"lag,":[125],"but":[126],"association":[128],"two":[131],"diminished":[132],"when":[133,172],"cause-and-effect":[135],"relationship":[136],"specifically":[138],"investigated.":[139],"These":[140],"results":[141],"suggest":[142],"that":[143,158,184,189],"multinational":[144],"companies":[145,192],"are":[146,198],"likely":[147],"place":[149],"more":[150],"emphasis":[151],"choice":[154],"development":[156,187],"strategies":[157,197],"successfully":[159],"lead":[160],"their":[162,176],"goal":[163],"rather":[164],"than":[165],"direct":[167],"expected":[170],"deciding":[173],"introduce":[175],"pharmaceutical":[177,191],"Our":[181],"findings":[182],"indicate":[183],"guidances":[188],"helps":[190],"decide":[193],"investment":[195],"also":[199],"key":[201],"narrowing":[203],"drugs.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}